Natera Acquires Assets From Invitae
(RTTNews) - Natera, Inc. (NTRA), a diagnostics company, Monday announced that it has acquired the non-invasive pre-natal screening and carrier screening business of medical genetics company, Invitae (NVTA).
Natera has made an upfront payment of $10 million and will pay an additional $42.5 million as potential milestone payments to Invitae.
On the other hand, Invitae will transition its non-invasive prenatal screening and carrier screening to Natera's customers.
On Friday, Natera shares closed at $66.63, down 1.38% on the Nasdaq and in pre-market activity, Invitae shares are trading at $0.44, up 3.51% on the New York Stock Exchange.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.